未登录

O

Ombretta Lenzi

University of Florence

H指数:16

被引数:689

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developing New 4-PIOL and 4-PHP Analogues for Photoinactivation of γ-Aminobutyric Acid Type A Receptors

ACS CHEMICAL NEUROSCIENCE

IF3.9

2019-10-075

OAAI

3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2012-08-0134

PREAI

Allergic Contact Dermatitis From Depilatory Wax

IF3.2

2012-05-012

PREAI

Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2011-06-0122

PRE

2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A3 Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2009-09-1055

PREAI

Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2009-03-2038

PREAI

Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: Molecular docking analysis and pharmacological studies

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2009-01-0122

PRE

Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2008-06-0140

PRE

Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system:: Synthesis and structure-activity relationships

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2008-03-0130

PRE

Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach:: From triazoloquinoxaline to a pyrimidine skeleton as a key study

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2007-11-3033

PREAI

New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.: Synthesis, pharmacological evaluation, and ligand-receptor modeling studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2007-08-0164

PREAI

Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists.: Synthesis, pharmacological, and molecular modeling studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2006-09-1255

PREAI

4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2006-06-0356

PREAI

1,2,4-triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists:: Synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substitued derivatives

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2005-11-1160

PREAI

1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists:: Synthesis, biological evaluation, and molecular modeling study

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2005-10-0173

PRE

Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c] quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2005-09-0132

PREAI

2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists

2-芳基-8-氯-1，2，4-三唑并 [1，5-a]quinoxalin-4-amines作为高效的A1和A3腺苷受体拮抗剂

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2005-02-0136

PRE

1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists:: Synthesis, pharmacological, and ligand-receptor modeling studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2004-06-0468

PREAI